Literature DB >> 646028

Clinical and histological kidney involvement in human kala-azar.

J R Weisinger, A Pinto, G A Velazquez, I Bronstein, J J Dessene, J F Duque, J Montenegro, F Tapanes, A R de Rousse.   

Abstract

A 19-year-old women developed prolonged fever, weight loss, hepatosplenomegaly, anemia, leukopenia, and hyperglobulinemia. Appropriate tests indicated that she had visceral leishmaniasis (kala-azar). Urinalysis demonstrated significant proteinuria and microhematuria with the presence of red cell casts. A kidney biopsy was performed. Light microscopy showed a slight mesangial thickening and segmental mesangial proliferation. Immunofluorescence demonstrated deposits of immunoglobulins A and M, complement, and fibrinogen. Electron microscopy showed subendothelial and intramembranous deposits. After treatment with N-methylglucamine antimonate the proteinuria and microhematuria disappeared and the patient recovered uneventfully.

Entities:  

Mesh:

Year:  1978        PMID: 646028     DOI: 10.4269/ajtmh.1978.27.357

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Immune complex glomerulonephritis in experimental kala-azar. II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters.

Authors:  A Sartori; M C Roque-Barreira; J Coe; A Campos-Neto
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Immunohistochemical study of renal fibropoiesis associated with dogs naturally and experimentally infected with two different strains of Leishmania (L.) infantum.

Authors:  Adriano F Alves; Ramon A Pereira; Helida M de Andrade; David M Mosser; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2019-11-06       Impact factor: 1.925

3.  Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).

Authors:  Michelle J C Oliveira; Geraldo B Silva Júnior; Krasnalhia Lívia S Abreu; Natália A Rocha; Ana Valeska V Garcia; Luiz F L G Franco; Rosa M S Mota; Alexandre B Libório; Elizabeth F Daher
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

4.  T cells, adhesion molecules and modulation of apoptosis in visceral leishmaniasis glomerulonephritis.

Authors:  Francisco A L Costa; Maria G Prianti; Teresa C Silva; Silvana M M S Silva; José L Guerra; Hiro Goto
Journal:  BMC Infect Dis       Date:  2010-05-11       Impact factor: 3.090

5.  Identification of leishmanial antigens in the sera of patients with American visceral leishmaniasis.

Authors:  T G Evans; R D Pearson
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

6.  Detection of anti-Leishmania immunoglobulin G antibodies in urine specimens of dogs with leishmaniasis.

Authors:  L Solano-Gallego; A Rodríguez; L Iniesta; M Arboix; M Portús; J Alberola
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

7.  Mesangial proliferative glomerulonephritis associated with progressive amyloid deposition in hamsters experimentally infected with Leishmania donovani.

Authors:  A V Oliveira; M C Roque-Barreira; A Sartori; A Campos-Neto; M A Rossi
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

8.  Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia.

Authors:  Workagegnehu Hailu; Rezika Mohamed; Helina Fikre; Saba Atnafu; Azeb Tadesse; Ermias Diro; Johan van Grienvsen
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

Review 9.  Renal involvement in leishmaniasis: a review of the literature.

Authors:  Anna Clementi; Giorgio Battaglia; Matteo Floris; Pietro Castellino; Claudio Ronco; Dinna N Cruz
Journal:  NDT Plus       Date:  2011-03-21

10.  Microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis.

Authors:  Neena Verma; Chandra Shekhar Lal; Vidyanand Rabidas; Krishna Pandey; Dharmendra Singh; Sanjay Kumar; Rakesh Bihari Verma; Pradeep Das
Journal:  Biomed Res Int       Date:  2013-06-23       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.